WASHINGTON, Nov. 26 -- Bureau of Industry and Security has issued a notice called: In the Matter of: Ghacham, Inc, 7340 Alondra Blvd, Paramount, California 90273; Order Denying Export Privileges. The... Read More
WASHINGTON, Nov. 26 -- Bureau of Industry and Security has issued a notice called: In the Matter of: James Mwangangi Kiilu, Inmate Number: 31358-510, FCI Beaumont Low, Federal Correctional Institution... Read More
WASHINGTON, Nov. 26 -- Bureau of Industry and Security has issued a notice called: In the Matter of: Pedro Mascorro, Inmate Number: 94824-510, FPC Montgomery, Federal Prison Camp, Maxwell Air Force Ba... Read More
WASHINGTON, Nov. 26 -- Bureau of Industry and Security has issued a notice called: In the Matter of: Federick Joseph Bergmann, Jr. Also Known as Frederick Bergmann, Inmate Number: 44293-510, FCI Miami... Read More
WASHINGTON, Nov. 26 -- Bureau of Industry and Security has issued a notice called: In the Matter of: Miguel Ocura-Arenas, Inmate Number: 26154-510, FCI Beaumont Low, Federal Correctional Institution, ... Read More
WASHINGTON, Nov. 26 -- Bureau of Industry and Security has issued a notice called: In the Matter of: Sadir Arvizu Velazquez, Inmate Number: 31345-510, FCI Forrest City Low, Federal Correctional Instit... Read More
WASHINGTON, Nov. 26 -- Bureau of Industry and Security has issued a notice called: Order Denying Export Privileges; In the Matter of: Mohamed Daoud Ghacham, Inmate Number: 10038-511, FCI Lompoc II, Fe... Read More
U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07247435) titled 'Role of CT in Tetralogy of Fallot Diagnosis' on Sept. 24. Brief Summary: To evaluate the r... Read More
U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249788) titled 'Resmiterom Efficacy & Safety in Patients With MASH' on Nov. 18. Brief Summary: Phase 4 cli... Read More
U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07248696) titled 'Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Na... Read More